← Leaderboards
Andre Fischer
Boston University Medical Campus
$1,068,511
Attributed
$3,205,534
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2022–24$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
Funding mix
By agency
NIH$3,205,534 · 2
By mechanism
RF1$2,384,981 · 1
R01$820,553 · 1
Top collaborators
- Jan Krzysztof Blusztajn3 shared
- Ivana Delalle3 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Catherine E. Costello$27,592,140
- Sudha Seshadri$50,696,682
- Jan Krzysztof Blusztajn$11,412,004
- Ivana Delalle$2,722,199
- Max O'Donnell$9,472,250
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposGenomeBloodElderlyFramingham Heart StudyFutureAdultDementiaBrain TissueEarly Detection BiomarkersAlzheimerâS Disease BiomarkerExperimental StudyBiological MarkersBiological ModelsDiagnosisBrainCognitiveData SetExperimental ModelsCandidate MarkerAutopsyDifferential ExpressionCellsGermany
Grant awards (3)
Long Non-coding RNAs as Therapeutic Targets and Biomarkers of Alzheimer's Disease and Related Dementias$820,553
R01 · FY2024 · AG
MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease$2,066,213
RF1 · FY2022 · AG
MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease$318,768
RF1 · FY2022 · AG